关于化学抗原受体T细胞治疗和病的最新进展
Juan León-Román1,2,3, Alexandra Esteves4, Gloria Iacoboni5
1Nephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, CSUR National Unit of Expertise for Complex Glomerular Diseases of Spain.
Current opinion in nephrology and hypertension
|June 23, 2025
概括
急性损伤 (AKI) 是化学抗原受体 (CAR) T细胞治疗后的常见并发症,通常在一个月内消失. 需要进一步的研究来理解AKI.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫治疗是一种免疫疗法.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法为血液性瘤提供高缓解率.
- 卡尔T细胞治疗与严重的并发症有关,包括细胞因子释放综合征 (CRS),神经毒性和急性损伤 (AKI).
研究的目的:
- 审查CAR T细胞治疗后AKI的发病率,风险因素和结果.
- 确定AKI预防和管理在CAR T细胞输液后未来研究的领域.
主要方法:
- 对CAR T细胞治疗并发症的当前文献的综述.
- 对AKI报告的病例和风险因素的分析.
主要成果:
- AKI是一种常见的并发症,通常在输液后的第一周内出现,并在一个月内消失.
- AKI的危险因素包括先前存在的慢性病 (CKD),CRS,神经毒性,抗生素使用和静脉注射对比剂.
- AKI通常是温和的,并且很快就会消失.
结论:
- AKI是一种常见的,但通常是CAR T细胞治疗的轻微并发症,具有快速恢复.
- 需要进一步的多中心前性研究来阐明AKI的病理生理学,并探索预防策略.
- 在以前患有CKD的患者中,AKI的长期结果需要进一步调查.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.5K
06:18Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
Published on: August 18, 2023
2.9K
相关概念视频
01:27Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
01:28Kidney Transplant I: Introduction
65
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
65